Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting

NCT03831178 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.

NCT NCT03831178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03831178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Lead sponsor
AHS Cancer Control Alberta
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 28, 2019
Completion date
September 30, 2030
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer